Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/42851
Tipo de documento
ArtigoDireito Autoral
Acesso restrito
Data de embargo
2025-12-31
Coleções
Metadata
Mostrar registro completo
HOW HEALTH ECONOMIC EVALUATION (HEE) CONTRIBUTES TO DECISION-MAKING IN PUBLIC HEALTH CARE: THE CASE OF BRAZIL
Health technology assessment
Decision making
Brazil
Invenções
Programas Nacionais de Saúde
Prática de Saúde Pública
Avaliação da Tecnologia Biomédica
Cobertura Universal do Seguro de Saúde
Análise Custo-Benefício
Comparação Transcultural
Tomada de Decisões Gerenciais
Título alternativo
Wie die Kosten-Nutzen-Bewertung zur Entscheidungsfindung im öffentlichen Gesundheitssektor beiträgt: am Beispiel BrasiliensAfiliação
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
State University of Rio de Janeiro. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. Rio de Janeiro, RJ, Brazil.
Resumo em Inglês
The universal access to a health care system for the Brazilian population was established in 1990. Brazil is a country with no tradition in the production and use of health economic evaluation (HEE) to guide decision making in the public health system. It is only within the last two decades that HEEs using a microeconomic approach have appeared in the academic field. On a national level, HEE and Health Technology Assessment (HTA), in a wider sense, were first taken into account in 2003. Two policies deserve to be mentioned - (i) the regulation of medicines in the Brazilian market, and (ii) science, technology and innovation policy. The latter required the fostering of applied research to encourage the application of methods which employ systematic reviews and economic analyses of cost-effectiveness to guide the incorporation of technologies in the Brazilian health care system. The Ministry of Health has initiated the process of incorporating these new technologies on a federal level during the last ten years. In spite of the improvement of HEE methods at Brazilian universities and research institutes, these technologies have not yet reached the governmental bodies. In Brazil, the main challenge lies in the production, interpretation and application of HEE to all technologies within the access scheme(s), and there is limited capacity building. Setting priorities can be the solution for Brazil to be able to perform HEE for relevant technologies within the access scheme(s) while the universal coverage system struggles with a triple burden of disease.
Palavras-chave em inglês
Health economic evaluationHealth technology assessment
Decision making
Brazil
DeCS
Acesso aos Serviços de SaúdeInvenções
Programas Nacionais de Saúde
Prática de Saúde Pública
Avaliação da Tecnologia Biomédica
Cobertura Universal do Seguro de Saúde
Análise Custo-Benefício
Comparação Transcultural
Tomada de Decisões Gerenciais
Compartilhar